Insiders Soleno Therapeutics, Inc.

Equities

SLNO

US8342033094

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
45.66 ^USD	+1.00%		-4.16%	+13.44%

May. 13	Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating	MT
May. 10	Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Soleno Therapeutics, Inc. Announces Gwen Melincoff, Intends Not Intend to Stand for Re-Election as Director	Apr. 22	CI
Soleno Therapeutics Insider Sold Shares Worth $784,645, According to a Recent SEC Filing	Apr. 04	MT
Soleno Therapeutics Names Meredith Manning as Chief Commercial Officer	Jan. 24	MT
Soleno Therapeutics Strengthens Leadership Team with Key Appointments	Jan. 24	CI
Soleno Therapeutics Insider Sold Shares Worth $1,412,431, According to a Recent SEC Filing	Dec. 15	MT
Soleno Therapeutics Insider Sold Shares Worth $1,182,828, According to a Recent SEC Filing	Dec. 14	MT
Soleno Therapeutics Insider Sold Shares Worth $222,177, According to a Recent SEC Filing	Dec. 01	MT
Soleno Therapeutics Insider Sold Shares Worth $1,471,049, According to a Recent SEC Filing	Dec. 01	MT
Soleno Therapeutics Appoints Matthew Pauls to Board of Directors	23-08-16	CI
Insider Buy: Soleno Therapeutics	23-06-01	MT
Insider Sell: Soleno Therapeutics	23-05-15	MT
Insider Trends: Soleno Therapeutics Insider Continues 90-Day Selling Trend	21-08-03	MT
Soleno Therapeutics, Inc. Announces Executive Changes	20-04-20	CI
Soleno Therapeutics, Inc. Announces Executive Changes	19-11-15	CI
Soleno Therapeutics Appoints Birgitte Volck to its Board of Directors	19-06-12	CI
Soleno Therapeutics, Inc. Announces Management Changes	19-04-29	CI
Soleno Therapeutics, Inc. Announces Appointment of Andrew Sinclair in Board of Directors	19-03-18	CI
Soleno Therapeutics, Inc Announces Board Changes	18-12-19	CI
Soleno Therapeutics, Inc. Announces Board and Committee Changes	18-10-22	CI
Soleno Therapeutics, Inc. Appoints Jonathan Wolter as Chief Financial Officer on Non-Interim Basis	18-06-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Soleno Therapeutics, Inc.

Equities

SLNO

US8342033094

Insiders

Filters